P2.05. A Novel Autoantibodies Panel Predicted the Prognosis of Advanced Non-Small Cell Lung Cancer Receiving Anti-PD1 Combined With Chemotherapy - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Liyuan Dai
Meta Tag
Speaker Liyuan Dai
Topic Metastatic NSCLC: Immunotherapy - Biomarker
prognostic autoantibody biomarkers
advanced non-small cell lung cancer
anti-PD1 combined with chemotherapy
proteomic screening
responder and non-responder patients
progression-free survival
validation phase
dynamic cohort
bioinformatics analyses
prognostic stratification
Powered By